What pediatric IBD assessment in China actually involves
Inflammatory bowel disease in children includes Crohn's disease, ulcerative colitis and IBD unclassified. A child's assessment is not a single appointment. It brings together a detailed history, growth and nutrition review, blood and stool tests, imaging, and usually endoscopy with biopsies. The pathology report matters because the diagnosis and the extent of disease shape treatment choices.
In China, this work is typically done within pediatric gastroenterology at tertiary hospitals. Some hospitals run combined clinics where gastroenterology, pediatric surgery, nutrition and radiology input is drawn together for complex cases. Whether a particular hospital has a dedicated pediatric IBD team, and how it organises that input, is something to confirm with the hospital rather than assume.
The first decision for an overseas family is not which medicine to start. It is whether the child's current diagnosis and disease activity are well enough established that a Chinese team can build on them, or whether further diagnostic work is needed first. That question belongs to the treating clinicians, who will review the records and decide what they can and cannot conclude from them.
The records that make a pediatric review possible
Children's IBD records differ from adult records in ways that matter. Growth is part of the disease picture, so serial height and weight measurements, and where available a plotted growth chart, help a new team understand how the condition has affected the child over time. Pubertal status and bone health assessments may also be relevant, depending on the child's age and history.
Endoscopy and colonoscopy reports should come with the histopathology reports, not just the visual description. The original biopsy slides or tissue blocks may be requested so that a Chinese pathologist can review them; whether a hospital requires this, or accepts a written report, is a question for that hospital. Imaging should be shared in a format the receiving team can open, ideally the original images rather than photographs of a screen.
A clear medication history is essential: which drugs, at what dose, for how long, and what happened. Include any biologics with dates and responses, any immunomodulators, steroids and their tapering, and any adverse reactions. A short summary letter from the current gastroenterologist, written in English or with a translation, is often more useful than a large unsorted file.
- Growth chart with serial height and weight
- Endoscopy and colonoscopy reports with histopathology
- Original biopsy slides or blocks, if the hospital asks
- Imaging in the original digital format
- Medication history with doses, dates and responses
- Current treatment plan and the main question for the new team
Questions to ask before committing to travel
A records-based opinion can clarify whether a Chinese team sees a role for itself in the child's care, but it does not establish hospital acceptance or final treatment eligibility. Families should ask directly what the review covers and what it cannot answer without seeing the child.
It is reasonable to ask whether the hospital has a pediatric gastroenterology service that regularly manages IBD, how the team handles children on biologics, and what it would need before considering a change or continuation of therapy. Ask whether the child would be seen by a pediatric specialist rather than an adult gastroenterologist, and how communication with the family's home team would work.
Language and consent deserve early attention. Ask who will explain the plan to the parents, whether interpretation is available for consent discussions, and how the child's own views will be included in decisions appropriate to their age. These are practical questions, not challenges to the hospital's authority.
Treatment decisions that stay with the clinical team
Pediatric IBD treatment can include exclusive enteral nutrition, corticosteroids, immunomodulators, biologics and surgery in selected situations. Which of these is appropriate depends on disease type, location, severity, growth impact, infection status and prior response. No article can decide that for a child, and a Chinese team will form its own view after reviewing the evidence.
Families sometimes travel hoping to access a specific medicine. Availability, prescribing rules and reimbursement differ between countries, and a medicine used at home may not be available in the same form or on the same terms in China. Rather than assume, ask the hospital's pediatric gastroenterology department which relevant therapies it can offer to a child of this age, and what monitoring it requires.
If the child is currently stable on treatment, the more important question may be continuity: how a transition of care would be managed, what happens if a medicine is interrupted, and who is responsible for monitoring. These questions should be answered in writing by the treating team before any change is made.
Safety, urgency and what should not wait
A child with severe abdominal pain, persistent vomiting, high fever, significant bleeding, dehydration or rapid weight loss needs urgent local medical assessment. Travel planning should not delay that. Similarly, a child who is deteriorating on current therapy should be reviewed by their existing team before an overseas appointment is arranged.
For children who are stable, the safety work is about preparation. Ask the hospital what it requires in terms of vaccination status, infection screening before biologics, and baseline tests. Ask how acute problems would be handled if they arose during a stay, and what the family should do outside clinic hours. The answers are hospital-specific and should be confirmed rather than assumed.
Parents should also consider the child's schooling, the length of any stay, and the emotional impact of care in an unfamiliar language environment. These are not clinical risks in themselves, but they affect how a family copes with a serious chronic condition away from home.
What a records-based opinion can and cannot settle
ChinaSpecialistCare provides information and non-clinical coordination. Our team can review a brief summary of the child's diagnosis, records and main question, identify obvious gaps, and suggest a relevant next step. This initial review is free and is not a diagnosis or a promise of acceptance by any hospital.
Where a family wants a records-based specialist opinion before travelling, a proxy consultation may be arranged with a relevant hospital specialist. It is optional and not a prerequisite for every appointment. For complex cases, a review involving more than one specialty may be discussed, with the scope and fee agreed first. Hospital consultation and treatment fees are separate from our coordination fees.
We can also help with appointment registration, hospital navigation and interpretation, and practical local arrangements. We do not decide suitability, prescribe treatment or guarantee outcomes. The treating hospital and its licensed clinicians make those decisions.
A practical next step
Start with a short summary rather than a complete medical archive: the child's age, diagnosis, current treatment, the main question, and a list of the records available. Send it through the enquiry form, email or WhatsApp. Our team will explain what else may be useful and how to share records securely after first contact.
Before any travel is booked, ask the receiving hospital in writing which records it needs, what its pediatric gastroenterology team can confirm remotely, and what remains to be decided after seeing the child. A clear answer to those questions is more useful than a long itinerary.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
